Clinic of Gastroenterohepatology, Medical Faculty Skopje, University of Skopje, Skopje, Macedonia.
Updates Surg. 2012 Sep;64(3):195-201. doi: 10.1007/s13304-012-0153-4. Epub 2012 Apr 11.
Topical formulations are widely used in anti-haemorrhoidal treatment, but often lacking controlled clinical trials. Here, we report the results from a controlled clinical trial performed with a new gel medical device (Proctoial) containing hyaluronic acid with tea tree oil and methyl-sulfonyl-methane as major components. The total number of 36 haemorrhoidal patients (grade 1-3) was enrolled in a double-blind, placebo-controlled clinical trial and divided into 2 equal parallel groups. The anal pain, pain during defecation, visible bleeding, pruritus and irritation/inflammation were recorded before and after 14-day treatment using a visual analogue scale both by the investigators and by the patients. Safety and tolerability of the treatments were also recorded. The new gel medical device statistically significantly reduced all the symptoms after the treatment compared to placebo. The results indicated also a very good tolerability and safety of the treatments.
局部制剂在抗痔疮治疗中被广泛应用,但往往缺乏对照临床试验。在这里,我们报告了一项含有透明质酸、茶树油和甲基磺酰甲烷作为主要成分的新型凝胶医疗设备(Proctoial)的对照临床试验结果。共有 36 名痔疮患者(1-3 级)参与了这项双盲、安慰剂对照临床试验,并分为两组。通过视觉模拟评分法,由研究者和患者分别在治疗前和治疗后 14 天记录肛门疼痛、排便时疼痛、可见出血、瘙痒和刺激/炎症等症状。还记录了治疗的安全性和耐受性。与安慰剂相比,新型凝胶医疗设备在治疗后统计学上显著减轻了所有症状。结果还表明,这些治疗方法具有很好的耐受性和安全性。